Pharma Industry
Industry: Email Alert RSS FeedPharma Marketletter
View more issues:
Articles in November, 2004 issue of Pharma Marketletter
- Pharma R&D remains vital to the UK
- Recordati's 3rd-qtr earnings rise 13%
- Shire Pharma sees 3rd-qtr net income rise 19%, but fails to inspire investors
- Sanofi-Aventis' 3rd-qtr sales rise 10.7%.
- Metabolic protein processing deficits may cause schizophrenia
- New Spanish Rx trade chief slams govt policies
- India's new patent bill expected to go before Parliament in December.
- 3rd-qtr profit for Chiron despite Fluvirin woes.
-
IPMG joins fight against fake drugs in Indonesia - by P S Sujarto, Jakarta
by P.S. Sujarto - French Rx R&D losing ground, says Academy
- Spain: cash benefits from Rx innovation
- Tokyo pharma stocks - week to November 8.
- US patent challenge for Sanofi-Aventis' Plavix - the risks from Canada.
- Stock Commentary - New York.
- US employees keen to shoulder more health responsibility, but do not know how: study.
- Stock Commentary - New York.
- W Virginia Senate backs Rx cost management
- Patients in UK "get less Rx info than elsewhere"
- Omega-3 fats benefit cardiovascular health, more US research shows.
- Letter from the Editor
- Ahead of election, Bush pledges funds for cancer trials, Rx benefit promo in 21 states.
- New EORTC cancer guidelines focus on treating anemia
- "Big savings" from US Free Market Drug Act
- Richter Gedeon's nine-month profit grows 7%
- US sales decline hits Santen results
- Tokyo pharma stocks - week to November 15.
- Tokyo pharma stocks - week to October 25.
- UPDATE: Serono tops forecasts as EPS rockets 54%
- New Data confirm benefits of AstraZeneca's Crestor in treating broad range of patients.
- Daiichi sees first-half revenues fall 2%.
- World Rx sales up 7% in year to September
- Fast-growing RNAi market shows no sign of slowing, says study.
- UK MPs warned of the costs to society of "disease-mongering and risk factor creep"
- New FDA initiative to protect US drug supply through RFID.
- Stock Commentary - Europe
- Can poor nations help the rich contain Rx costs?
- CAT's fiscal 2004 revenues rocket 82%
- Editor's views: Vioxx fall-out; impact on AstraZeneca and pharma industry.
- Better lifecycle management essential for pharmaceutical industry success; new study.
- EpiTan focuses on Melanotan, a potential blockbuster Olife styleO drug.
- French antibiotics consumption falls 16% since 2002, with 25% target by 2008.
- Ranbaxy's 3rd-qtr 2004 sales jump 19%
- Merck KGaA's 3rd-qtr profit leaps 43%
- New UK pharmacy contract announced.
- US pharma groups tell Pres Bush of their needs.
- Serono showcases business and plays down rival drug at financial roadshow.
- Senetek signs letter of intent to buy IGI
- Stock Commentary - Europe
- California voters back stem cell research.
- Wyeth showcases novel antibiotic tigecycline, with activity against MRSA
- Promising Ph II data for Abbott's ABT-874.
- Spain mulling free "morning-after" pill
- New UK pharma commission members to be barred from links with industry.
- Canadian pharmacists/patients/seniors group backs govt on Internet pharmacy.
- Boehringer Ingelheim's tipranavir beats rival HIV drugs in a pivotal Phase III trial.
- Elan/Biogen Idec's Tysabri Oked by FDA.
- AstraZeneca to buy 19.9% stake in CAT alongside research deal to boost pipeline.
- US FDA "fiasco dispels 'branded = safe' spin".
- Perrigo to buy Israel's Agis in $818 million deal, to create global generics provider
- Pfizer and GSK drug anti-counterfeiting moves
- GSK/MedImmune's cervical cancer vaccine shows promise; Lancet study.
- S Africa Rx prices fall, but are patients benefiting?
- LEEM advances French biopharma proposals
- GSK reveals CNS research portfolio; highlights '381 and radafaxine.
- NIST begins new gene expression profiling program
- Strong 1st-half income growth for Takeda.
- Carl Icahn continues campaign to derail Mylan's planned acquisition of King Pharma.
- German drugmakers call for price rises
- NeuroSearch lifts 2004 target on 3rd-qtr results
- US uninsured "pay 78% more than best Rx prices".
- GlaxoSmithKline's profit drops again for 3rd qtr, on flagging sales and weak dollar
- Euro bio/generics mkt "to hit $21.2B in 2010".
- Indian govt committee reports on drug prices
- US FDA announces guidance for generics.
- Visually-impaired "find Rx labels, info too small".
- Sanofi-Aventis' Acomplia provides long-term cardiovascular benefits; two-year study.
-
Editor's views on US HHS/FDA appointments; new UK regulatory agency
by Barbara Obstoj - Sankyo's 1st-half in line with forecasts.
- Stock Commentary - Tokyo.
- BIO urges US Congress to keep patent fees at PTO.
Brought to you by CBS MoneyWatch.com
- Best- and Worst-Paid College Degrees
- 6 Things You Should Never Do on Twitter or Facebook
- How Much Sleep Do You Really Need?
- 6 Big Myths about Gas Mileage
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- Make running easier: with this unique 'pose running' technique, you'll learn to actually enjoy your fat-burning sessions
- 50 home remedies that work: these safe, fast, and effective fixes will relieve what ails you - Cover Story
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich



